NCT00630786View on ClinicalTrials.gov

Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer Study

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

May 31, 2009

Study Completion Date

November 30, 2010

Conditions
Colon CancerColorectal CancerRectal CancerMetastatic Colorectal CancerOncology
Interventions
DRUG

Panitumumab

Administered by intravenous infusion

DRUG

Conatumumab

Administered by intravenous infusion

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY